Innova Captab Limited — PPTs, 07-05-2026: Investor Presentation

**Business Performance:** Innova Captab reported a strong Q4 FY26 with revenue up 42% YoY, achieving record FY26 revenue, growing 31%. Both CDMO and Branded Generics segments showed robust momentum. Exports contributed 28% to Q4 and 31% to FY26 revenue.

**Growth Drivers & Key Developments:** Strategic growth is fueled by expanding product offerings and capacity. This includes the Sharon acquisition and the January 2025 commercialization of the ₹480+ Cr Jammu plant, which is now successfully completing client audits and ramping up. The company also secured important UK-MHRA and PIC/S certifications, enhancing market access, and maintains a strong R&D focus.

**Financial Highlights:** Q4 FY26 saw revenue at ₹447.8 Cr, EBITDA ₹66.7 Cr (14.9% margin), and PAT ₹38.1 Cr (8.5% margin). For the full FY26, revenue was ₹1,630 Cr, EBITDA ₹250.3 Cr (15.4% margin), and PAT ₹140.9 Cr (8.6% margin). FY26 EPS was ₹24.63.

**Management Outlook:** Management is confident in sustaining momentum and delivering long-term value, emphasizing operational excellence and leveraging new capacity and market certifications.